MW
Michael Weiser
Director

Michael Weiser insider trades: Iovance Biotherapeutics (IOVA) stock buys and sales

Director, Iovance Biotherapeutics Last trade May 31, 2022 96 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2006
14
Companies
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

and 8 more companies

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 31, 2022IOVA↑ Buy$68K
Jun 5, 2012CHTP↑ Buy$7K
May 25, 2011ZIOP↓ Sell$98K
Oct 3, 2008CHTP↑ Buy$3K
Sep 24, 2008CHTP↑ Buy$4K
May 15, 2008HNAB↑ Buy$8K
Aug 23, 2006CHTP.OB↑ Buy$3K
Jul 12, 2006MHA↑ Buy$4K
Jul 11, 2006HNAB↑ Buy$8K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michael Weiser's insider trades

Michael Weiser is a director at Iovance Biotherapeutics (IOVA). Since Jul 11, 2006, Michael has reported 8 open-market purchases worth $105K and 1 sale worth $98K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (68 filings), other transactions (13 filings), shares withheld for taxes (9 filings), option exercises (7 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IOVA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.